Release Date: 29/01/19 08:18 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 2.44MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%